Baidu
map

消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2019 AIGO/SIGENP指南：胃肠道疾病慢性贫血的诊断

2019-02-11 国外消化科相关专家小组（统称） Dig Liver Dis. 2019 Feb 11.

胃肠道疾病慢性贫血

2019年2月，意大利医院胃肠病学协会(AIGO)联合意大利儿科胃肠病学、肝病学和营养学会 (SIGENP)共同发布了胃肠道疾病慢性贫血的诊断指南，贫血是一种常见的病理情况，约占成年人群约有5%。铁缺乏是最常见的病因。本文主要针对胃肠道疾病慢性贫血的诊断提出指导建议，内容涉及贫血分类、诊断以及标志物，内镜检查的作用，影像学检查，贫血的特殊因素，非缺铁性贫血的治疗方法，儿童时期贫血的管理等。

中文标题：

2019 AIGO/SIGENP指南：胃肠道疾病慢性贫血的诊断

英文标题：

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGE

发布机构：

国外消化科相关专家小组（统称）

发布日期：

2019-02-11

简要介绍：

2019年2月，意大利医院胃肠病学协会(AIGO)联合意大利儿科胃肠病学、肝病学和营养学会 (SIGENP)共同发布了胃肠道疾病慢性贫血的诊断指南，贫血是一种常见的病理情况，约占成年人群约有5%。铁缺乏是最常见的病因。本文主要针对胃肠道疾病慢性贫血的诊断提出指导建议，内容涉及贫血分类、诊断以及标志物，内镜检查的作用，影像学检查，贫血的特殊因素，非缺铁性贫血的治疗方法，儿童时期贫血的管理等。 

拓展指南：与贫血相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 AIGO/SIGENP指南：胃肠道疾病慢性贫血的诊断)] GetToolGuiderByIdResponse(projectId=1, id=0960f1c001e16725, title=2019 AIGO/SIGENP指南：胃肠道疾病慢性贫血的诊断, enTitle=Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGE, guiderFrom=Dig Liver Dis. 2019 Feb 11., authorId=null, author=, summary=2019年2月，意大利医院胃肠病学协会(AIGO)联合意大利儿科胃肠病学、肝病学和营养学会 (SIGENP)共同发布了胃肠道疾病慢性贫血的诊断指南，贫血是一种常见的病理情况，约占成年人群约有5%。铁缺乏是最常见的病因。本文主要针对胃肠道疾病慢性贫血的诊断提出指导建议，内容涉及贫血分类、诊断以及标志物，内镜检查的作用，影像学检查，贫血的特殊因素，非缺铁性贫血的治疗方法，儿童时期贫血的管理等。 , cover=, journalId=null, articlesId=null, associationId=950, associationName=国外消化科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Mon Feb 11 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年2月，意大利医院胃肠病学协会(AIGO)联合意大利儿科胃肠病学、肝病学和营养学会 (SIGENP)共同发布了胃肠道疾病慢性贫血的诊断指南，贫血是一种常见的病理情况，约占成年人群约有5%。铁缺乏是最常见的病因。本文主要针对胃肠道疾病慢性贫血的诊断提出指导建议，内容涉及贫血分类、诊断以及标志物，内镜检查的作用，影像学检查，贫血的特殊因素，非缺铁性贫血的治疗方法，儿童时期贫血的管理等。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>贫血</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=2e5881c001688e95" title="儿童非输血依赖型地中海贫血的诊治和管理专家共识" target=_blank>儿童非输血依赖型地中海贫血的诊治和管理专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=f95081c0016e82bf" title="非输血依赖型地中海贫血诊断与治疗中国专家共识（2018年版）" target=_blank>非输血依赖型地中海贫血诊断与治疗中国专家共识（2018年版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=064d21c0016e5752" title="患者血液管理——术前贫血诊疗专家共识" target=_blank>患者血液管理——术前贫血诊疗专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=b4fb11c0016395ff" title="2018 儿科重症监护输血和贫血专家倡议：儿童重症患者红细胞输注建议" target=_blank>2018 儿科重症监护输血和贫血专家倡议：儿童重症患者红细胞输注建议</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c55e21c001628904" title="2018 香港专家组联合建议：消化道出血患者贫血的管理" target=_blank>2018 香港专家组联合建议：消化道出血患者贫血的管理</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E8%B4%AB%E8%A1%80" target=_blank>有关贫血更多指南</a></ul>, tagList=[TagDto(tagId=88085, tagName=胃肠道疾病慢性贫血)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6914, appHits=322, showAppHits=0, pcHits=5050, showPcHits=2180, likes=264, shares=7, comments=8, approvalStatus=1, publishedTime=Sun Mar 24 12:00:10 CST 2019, publishedTimeString=2019-02-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 24 12:00:10 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:40:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 AIGO/SIGENP指南：胃肠道疾病慢性贫血的诊断)])
2019 AIGO/SIGENP指南：胃肠道疾病慢性贫血的诊断
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1248131, encodeId=553912481318b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be1a8317767, createdName=ms3000001946682904, createdTime=Fri Sep 09 15:38:59 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812915, encodeId=15c38129159a, content=已经学习<a href='/topic/show?id=a3e41038167f' target=_blank style='color:#2F92EE;'>#IDA#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103816, encryptionId=a3e41038167f, topicName=IDA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Aug 25 01:02:20 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812913, encodeId=af8f81291319, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:34 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812912, encodeId=455a812912f0, content=已经学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:12 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812903, encodeId=294c812903b0, content=关于Ida的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:55:13 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2022-09-09 ms3000001946682904

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1248131, encodeId=553912481318b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be1a8317767, createdName=ms3000001946682904, createdTime=Fri Sep 09 15:38:59 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812915, encodeId=15c38129159a, content=已经学习<a href='/topic/show?id=a3e41038167f' target=_blank style='color:#2F92EE;'>#IDA#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103816, encryptionId=a3e41038167f, topicName=IDA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Aug 25 01:02:20 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812913, encodeId=af8f81291319, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:34 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812912, encodeId=455a812912f0, content=已经学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:12 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812903, encodeId=294c812903b0, content=关于Ida的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:55:13 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 仁心济世

    已经学习#IDA#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1248131, encodeId=553912481318b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be1a8317767, createdName=ms3000001946682904, createdTime=Fri Sep 09 15:38:59 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812915, encodeId=15c38129159a, content=已经学习<a href='/topic/show?id=a3e41038167f' target=_blank style='color:#2F92EE;'>#IDA#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103816, encryptionId=a3e41038167f, topicName=IDA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Aug 25 01:02:20 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812913, encodeId=af8f81291319, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:34 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812912, encodeId=455a812912f0, content=已经学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:12 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812903, encodeId=294c812903b0, content=关于Ida的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:55:13 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 LeoQ

    感谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1248131, encodeId=553912481318b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be1a8317767, createdName=ms3000001946682904, createdTime=Fri Sep 09 15:38:59 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812915, encodeId=15c38129159a, content=已经学习<a href='/topic/show?id=a3e41038167f' target=_blank style='color:#2F92EE;'>#IDA#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103816, encryptionId=a3e41038167f, topicName=IDA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Aug 25 01:02:20 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812913, encodeId=af8f81291319, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:34 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812912, encodeId=455a812912f0, content=已经学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:12 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812903, encodeId=294c812903b0, content=关于Ida的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:55:13 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 LeoQ

    已经学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1248131, encodeId=553912481318b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be1a8317767, createdName=ms3000001946682904, createdTime=Fri Sep 09 15:38:59 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812915, encodeId=15c38129159a, content=已经学习<a href='/topic/show?id=a3e41038167f' target=_blank style='color:#2F92EE;'>#IDA#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103816, encryptionId=a3e41038167f, topicName=IDA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Aug 25 01:02:20 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812913, encodeId=af8f81291319, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:34 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812912, encodeId=455a812912f0, content=已经学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 01:01:12 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812903, encodeId=294c812903b0, content=关于Ida的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=LeoQ, createdTime=Tue Aug 25 00:55:13 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 LeoQ

    关于Ida的指南

    0

Baidu
map
Baidu
map
Baidu
map